Mersana Therapeutics Inc
MRSN·Stocks·Biotechnology·United States·Nasdaq·USD
Price
$25.01
Today
-14.0%
YTD
-13.4%
About
Founded in 2001, Mersana Therapeutics works to develop antibody-drug conjugates (ADC) for cancer patients. Operating within the US, the company has its headquarters in Cambridge, Massachusetts. Using the MRSN ticker, Mersana Therapeutics is listed on the NASDAQ GS. Use your eToro watchlist to keep track of MRSN stock price changes.
Price chart
Closing price history for MRSN (1D candles).
Open positions
Current open positions for this instrument from your live portfolio.
Open positions
0
Unrealized return
+0.0%
No open positions exist for this instrument at the moment.
Financial insights
Valuation
P/E (TTM)-2.06
P/S (TTM)4.38
P/B (TTM)-2.44
Market cap$145.36M
Cap tierMicro-cap
Industry avg P/E-2.03
Profitability
Gross margin96.73%
EBIT margin-202.99%
Net margin-68.53%
ROE-505.14%
ROA-60.36%
Earnings & Revenue
Revenue (TTM)$33.18M
Revenue growth (1Y)-4.8%
EPS (TTM)-$14.08
Free cash flow$-74.37M
Total debt$2.29M
Dividends & Risk
Dividend rate$0.00
Dividend yield0.00%
Beta (5Y)1.87
Employees102
Next earnings3 Mar '26
Trade history
Closed trades
0
Realized return
+0.0%
No stored closed trades exist for this instrument yet.